No abstract available
Publication types
-
Clinical Trial, Phase I
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Alopecia Areata / diagnosis
-
Alopecia Areata / drug therapy*
-
Alopecia Areata / immunology
-
Dose-Response Relationship, Drug
-
Female
-
Humans
-
Interleukin-2 / administration & dosage*
-
Interleukin-2 / adverse effects
-
Killer Cells, Natural / drug effects*
-
Killer Cells, Natural / immunology
-
Male
-
Middle Aged
-
Placebos / administration & dosage
-
Placebos / adverse effects
-
Prospective Studies
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / adverse effects
-
Severity of Illness Index
-
T-Lymphocytes, Regulatory / drug effects*
-
T-Lymphocytes, Regulatory / immunology
-
Treatment Outcome
-
Young Adult
Substances
-
IL2 protein, human
-
Interleukin-2
-
Placebos
-
Recombinant Proteins